Skip to main content
Top
Published in: BMC Musculoskeletal Disorders 1/2022

Open Access 01-12-2022 | Research

Validation of the Musculoskeletal Health Questionnaire in a general population sample: a cross-sectional online survey in Hungary

Authors: Áron Hölgyesi, Gyula Poór, Petra Baji, Zsombor Zrubka, Miklós Farkas, Ágota Dobos, László Gulácsi, Levente Kovács, Márta Péntek

Published in: BMC Musculoskeletal Disorders | Issue 1/2022

Login to get access

Abstract

Background

The Versus Arthritis Musculoskeletal Health Questionnaire (MSK-HQ) measures symptom severity and health-related quality of life (HRQoL) of people with musculoskeletal (MSK) conditions. We aimed to test the psychometric properties of the MSK-HQ among the general adult population and identify the determinants of MSK-HQ states. In addition, we aimed to explore the relationship between MSK-HQ and standard well-being measurement tools.

Methods

The translation proccess of the MSK-HQ into Hungarian followed the standard methods provided by the developer. A cross-sectional online survey was performed in Hungary involving a population normative sample (N = 2004, women: 53.1%; mean age: 48.3, SD = 16.6 years). Socio-demographic characteristics and self-reported MSK disorders were recorded. Alongside the MSK-HQ, standard measures of HRQoL (EQ-5D-5L), physical functioning (HAQ-DI) and well-being (ICECAP-A/O, WHO-5, Happiness VAS) were applied. Clinical and convergent validity were assessed by subgroup comparisons (Mann–Whitney-U and Kruskal–Wallis tests) and Spearman’s rank correlations. Internal consistency was assessed by Cronbach’s alpha. Test–retest reliability (N = 50) was evaluated by intraclass correlation coefficient (ICC). Predictors of MSK-HQ were analysed by ordinary least square multiple regressions.

Results

The mean MSK-HQ index score was 44.1 (SD = 9.9). MSK-HQ scores were significantly lower in subgroups with self-reported MSK disorders. Correlations were strong between MSK-HQ and EQ-5D-5L (0.788), EQ VAS (0.644) and HAQ-DI (-0.698) and moderate with the well-being measures (p < 0.05). Cronbach’s alpha was 0.924 and ICC was 0.936 (p < 0.05). Being a man, living in the capital, having higher income and education were positively associated with MSK-HQ scores.

Conclusions

This is the first study to prove the validity and reliability of the MSK-HQ among the general public. The impact of socio-demographic characteristics on MSK-HQ scores deserves consideration in clinical studies.
Appendix
Available only for authorised users
Literature
1.
go back to reference Global Burden of Disease Study 2013 Collaborators. Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet (London, England). 2015;386(9995):743–800. Global Burden of Disease Study 2013 Collaborators. Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet (London, England). 2015;386(9995):743–800.
2.
go back to reference Woolf AD, Erwin J, March L. The need to address the burden of musculoskeletal conditions. Best Pract Res Clin Rheumatol. 2012;26(2):183–224.CrossRef Woolf AD, Erwin J, March L. The need to address the burden of musculoskeletal conditions. Best Pract Res Clin Rheumatol. 2012;26(2):183–224.CrossRef
3.
go back to reference El Miedany Y. Patient reported outcome measures in Rheumatic diseases. Switzerland: Springer International Publishing AG Switzerland; 2016. p. 449.CrossRef El Miedany Y. Patient reported outcome measures in Rheumatic diseases. Switzerland: Springer International Publishing AG Switzerland; 2016. p. 449.CrossRef
4.
go back to reference Hill JC, Thomas E, Hill S, Foster NE, van der Windt DA. Development and validation of the keele Musculoskeletal Patient Reported Outcome Measure (MSK-PROM). PLoS ONE. 2015;10(4):e0124557.CrossRef Hill JC, Thomas E, Hill S, Foster NE, van der Windt DA. Development and validation of the keele Musculoskeletal Patient Reported Outcome Measure (MSK-PROM). PLoS ONE. 2015;10(4):e0124557.CrossRef
5.
go back to reference Delgado DA, Lambert BS, Boutris N, McCulloch PC, Robbins AB, Moreno MR, et al. Validation of digital visual analog scale pain scoring with a traditional paper-based visual analog scale in adults. J Am Acad Orthop Surg Glob Res Rev. 2018;2(3):e088-e.PubMedPubMedCentral Delgado DA, Lambert BS, Boutris N, McCulloch PC, Robbins AB, Moreno MR, et al. Validation of digital visual analog scale pain scoring with a traditional paper-based visual analog scale in adults. J Am Acad Orthop Surg Glob Res Rev. 2018;2(3):e088-e.PubMedPubMedCentral
6.
go back to reference Gossec L, Paternotte S, Aanerud GJ, Balanescu A, Boumpas DT, Carmona L, et al. Finalisation and validation of the rheumatoid arthritis impact of disease score, a patient-derived composite measure of impact of rheumatoid arthritis: a EULAR initiative. Ann Rheum Dis. 2011;70(6):935–42.CrossRef Gossec L, Paternotte S, Aanerud GJ, Balanescu A, Boumpas DT, Carmona L, et al. Finalisation and validation of the rheumatoid arthritis impact of disease score, a patient-derived composite measure of impact of rheumatoid arthritis: a EULAR initiative. Ann Rheum Dis. 2011;70(6):935–42.CrossRef
7.
go back to reference Gossec L, de Wit M, Kiltz U, Braun J, Kalyoncu U, Scrivo R, et al. A patient-derived and patient-reported outcome measure for assessing psoriatic arthritis: elaboration and preliminary validation of the Psoriatic Arthritis Impact of Disease (PsAID) questionnaire, a 13-country EULAR initiative. Ann Rheum Dis. 2014;73(6):1012–9.CrossRef Gossec L, de Wit M, Kiltz U, Braun J, Kalyoncu U, Scrivo R, et al. A patient-derived and patient-reported outcome measure for assessing psoriatic arthritis: elaboration and preliminary validation of the Psoriatic Arthritis Impact of Disease (PsAID) questionnaire, a 13-country EULAR initiative. Ann Rheum Dis. 2014;73(6):1012–9.CrossRef
8.
go back to reference Hill JC, Kang S, Benedetto E, Myers H, Blackburn S, Smith S, et al. Development and initial cohort validation of the Arthritis Research UK Musculoskeletal Health Questionnaire (MSK-HQ) for use across musculoskeletal care pathways. Int J Environ Res Public Health. 2016;6(8):e012331. Hill JC, Kang S, Benedetto E, Myers H, Blackburn S, Smith S, et al. Development and initial cohort validation of the Arthritis Research UK Musculoskeletal Health Questionnaire (MSK-HQ) for use across musculoskeletal care pathways. Int J Environ Res Public Health. 2016;6(8):e012331.
9.
go back to reference Norton S, Ellis B, Santana Suárez B, Schwank S, Fitzpatrick R, Price A, et al. Validation of the Musculoskeletal Health Questionnaire in inflammatory arthritis: a psychometric evaluation. Rheumatology (Oxford). 2019;58(1):45–51.CrossRef Norton S, Ellis B, Santana Suárez B, Schwank S, Fitzpatrick R, Price A, et al. Validation of the Musculoskeletal Health Questionnaire in inflammatory arthritis: a psychometric evaluation. Rheumatology (Oxford). 2019;58(1):45–51.CrossRef
10.
go back to reference Gibbons E, Fitzpatrick R. An alternative approach to implementing patient-reported outcome measures. Pilot Feasibility Stud. 2018;4(1):96.CrossRef Gibbons E, Fitzpatrick R. An alternative approach to implementing patient-reported outcome measures. Pilot Feasibility Stud. 2018;4(1):96.CrossRef
11.
go back to reference Algarni FS, Alotaibi AN, Altowaijri AM, Al-Sobayel H. Cross-cultural adaptation and validation of the Arabic Version of Musculoskeletal Health Questionnaire (MSK-HQ-Ar). Int J Environ Res Public Health. 2020;17(14):5168 Algarni FS, Alotaibi AN, Altowaijri AM, Al-Sobayel H. Cross-cultural adaptation and validation of the Arabic Version of Musculoskeletal Health Questionnaire (MSK-HQ-Ar). Int J Environ Res Public Health. 2020;17(14):5168
12.
go back to reference Akkubak Y, AnaforoĞlu KÜlÜnkoĞlu B. Reliability and validity of the Turkish Version of Arthritis Research UK Musculoskeletal Health Questionnaire. Arch Rheumatol. 2020;35(2):155–62. Akkubak Y, AnaforoĞlu KÜlÜnkoĞlu B. Reliability and validity of the Turkish Version of Arthritis Research UK Musculoskeletal Health Questionnaire. Arch Rheumatol. 2020;35(2):155–62.
13.
go back to reference Price AJ, Ogollah R, Kang S, Hay E, Barker KL, Benedetto E, et al. Determining responsiveness and meaningful changes for the Musculoskeletal Health Questionnaire (MSK-HQ) for use across musculoskeletal care pathways. BMJ Open. 2019;9(10):e025357.CrossRef Price AJ, Ogollah R, Kang S, Hay E, Barker KL, Benedetto E, et al. Determining responsiveness and meaningful changes for the Musculoskeletal Health Questionnaire (MSK-HQ) for use across musculoskeletal care pathways. BMJ Open. 2019;9(10):e025357.CrossRef
14.
go back to reference Galeoto G, Piepoli V, Ciccone E, Mollica R, Federici C, Magnifica F, et al. Musculoskeletal health questionnaire: translation, cultural adaptation and validation of the Italian version (MSK-HQ-I). Muscles Ligaments Tendons J. 2019;9(2):295–303.CrossRef Galeoto G, Piepoli V, Ciccone E, Mollica R, Federici C, Magnifica F, et al. Musculoskeletal health questionnaire: translation, cultural adaptation and validation of the Italian version (MSK-HQ-I). Muscles Ligaments Tendons J. 2019;9(2):295–303.CrossRef
15.
go back to reference Karstens S, Christiansen DH, Brinkmann M, Hahm M, Mc CG, Hill JC, et al. German translation, cross-cultural adaptation and validation of the Musculoskeletal Health Questionnaire: a cohort study. Arch Rheumatol. 2020;56(6):771–9. Karstens S, Christiansen DH, Brinkmann M, Hahm M, Mc CG, Hill JC, et al. German translation, cross-cultural adaptation and validation of the Musculoskeletal Health Questionnaire: a cohort study. Arch Rheumatol. 2020;56(6):771–9.
16.
go back to reference Christiansen DH, McCray G, Winding TN, Andersen JH, Nielsen KJ, Karstens S, et al. Measurement properties of the musculoskeletal health questionnaire (MSK-HQ): a between country comparison. Health Qual Life Outcomes. 2020;18(1):200.CrossRef Christiansen DH, McCray G, Winding TN, Andersen JH, Nielsen KJ, Karstens S, et al. Measurement properties of the musculoskeletal health questionnaire (MSK-HQ): a between country comparison. Health Qual Life Outcomes. 2020;18(1):200.CrossRef
17.
go back to reference Scott DIC, McCray DG, Lancaster PG, Foster PNE, Hill DJC. Validation of the Musculoskeletal Health Questionnaire (MSK-HQ) in primary care patients with musculoskeletal pain. Semin Arthritis Rheum. 2020;50(5):813–20.CrossRef Scott DIC, McCray DG, Lancaster PG, Foster PNE, Hill DJC. Validation of the Musculoskeletal Health Questionnaire (MSK-HQ) in primary care patients with musculoskeletal pain. Semin Arthritis Rheum. 2020;50(5):813–20.CrossRef
18.
go back to reference Tingulstad A, Van Tulder MW, Rysstad T, Tveter AT, Hill JC, Grotle M. Validity and reliability of the Norwegian version of the Musculoskeletal Health Questionnaire in people on sick leave. Health Qual Life Outcomes. 2021;19(1):191.CrossRef Tingulstad A, Van Tulder MW, Rysstad T, Tveter AT, Hill JC, Grotle M. Validity and reliability of the Norwegian version of the Musculoskeletal Health Questionnaire in people on sick leave. Health Qual Life Outcomes. 2021;19(1):191.CrossRef
19.
go back to reference Riva S, Pravettoni G. Value-Based model: a new perspective in medical decision-making. Front Public Health. 2016;4:118 Riva S, Pravettoni G. Value-Based model: a new perspective in medical decision-making. Front Public Health. 2016;4:118
20.
go back to reference Fautrel B, Alten R, Kirkham B, de la Torre I, Durand F, Barry J, et al. Call for action: how to improve use of patient-reported outcomes to guide clinical decision making in rheumatoid arthritis. Rheumatol Int. 2018;38(6):935–47.CrossRef Fautrel B, Alten R, Kirkham B, de la Torre I, Durand F, Barry J, et al. Call for action: how to improve use of patient-reported outcomes to guide clinical decision making in rheumatoid arthritis. Rheumatol Int. 2018;38(6):935–47.CrossRef
21.
go back to reference Proud L, McLoughlin C, Kinghorn P. ICECAP-O, the current state of play: a systematic review of studies reporting the psychometric properties and use of the instrument over the decade since its publication. Qual Life Res. 2019;28(6):1429–39.CrossRef Proud L, McLoughlin C, Kinghorn P. ICECAP-O, the current state of play: a systematic review of studies reporting the psychometric properties and use of the instrument over the decade since its publication. Qual Life Res. 2019;28(6):1429–39.CrossRef
22.
go back to reference Versteegh M, Knies S, Brouwer W. From good to better: new dutch guidelines for economic evaluations in healthcare. Pharmacoeconomics. 2016;34(11):1071–4.CrossRef Versteegh M, Knies S, Brouwer W. From good to better: new dutch guidelines for economic evaluations in healthcare. Pharmacoeconomics. 2016;34(11):1071–4.CrossRef
23.
go back to reference Hicks S, Tinkler L, Allin P. Measuring subjective well-being and its potential role in policy: perspectives from the UK Office for National Statistics. Soc Indic Res. 2013;114(1):73–86.CrossRef Hicks S, Tinkler L, Allin P. Measuring subjective well-being and its potential role in policy: perspectives from the UK Office for National Statistics. Soc Indic Res. 2013;114(1):73–86.CrossRef
26.
go back to reference Cox B, van Oyen H, Cambois E, Jagger C, le Roy S, Robine JM, et al. The reliability of the minimum European health module. Int J Public Health. 2009;54(2):55–60.CrossRef Cox B, van Oyen H, Cambois E, Jagger C, le Roy S, Robine JM, et al. The reliability of the minimum European health module. Int J Public Health. 2009;54(2):55–60.CrossRef
27.
go back to reference Herdman M, Gudex C, Lloyd A, Janssen M, Kind P, Parkin D, et al. Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L). Qual Life Res. 2011;20(10):1727–36.CrossRef Herdman M, Gudex C, Lloyd A, Janssen M, Kind P, Parkin D, et al. Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L). Qual Life Res. 2011;20(10):1727–36.CrossRef
28.
go back to reference Rencz F, Brodszky V, Gulácsi L, Golicki D, Ruzsa G, Pickard AS, et al. Parallel valuation of the EQ-5D-3L and EQ-5D-5L by time trade-off in Hungary. Value Health. 2020;23(9):1235–45.CrossRef Rencz F, Brodszky V, Gulácsi L, Golicki D, Ruzsa G, Pickard AS, et al. Parallel valuation of the EQ-5D-3L and EQ-5D-5L by time trade-off in Hungary. Value Health. 2020;23(9):1235–45.CrossRef
29.
go back to reference Fries JF, Spitz P, Kraines RG, Holman HR. Measurement of patient outcome in arthritis. Arthritis Rheum. 1980;23(2):137–45.CrossRef Fries JF, Spitz P, Kraines RG, Holman HR. Measurement of patient outcome in arthritis. Arthritis Rheum. 1980;23(2):137–45.CrossRef
30.
go back to reference Al-Janabi H, Flynn TN, Coast J. Development of a self-report measure of capability wellbeing for adults: the ICECAP-A. Qual Life Res. 2012;21(1):167–76.CrossRef Al-Janabi H, Flynn TN, Coast J. Development of a self-report measure of capability wellbeing for adults: the ICECAP-A. Qual Life Res. 2012;21(1):167–76.CrossRef
31.
go back to reference Coast J, Flynn TN, Natarajan L, Sproston K, Lewis J, Louviere JJ, et al. Valuing the ICECAP capability index for older people. Soc Sci Med. 2008;67(5):874–82.CrossRef Coast J, Flynn TN, Natarajan L, Sproston K, Lewis J, Louviere JJ, et al. Valuing the ICECAP capability index for older people. Soc Sci Med. 2008;67(5):874–82.CrossRef
32.
go back to reference Baji P, Farkas M, Dobos Á, Zrubka Z, Gulácsi L, Brodszky V, et al. Capability of well-being: validation of the Hungarian version of the ICECAP-A and ICECAP-O questionnaires and population normative data. Qual Life Res. 2020;29(10):2863–74.CrossRef Baji P, Farkas M, Dobos Á, Zrubka Z, Gulácsi L, Brodszky V, et al. Capability of well-being: validation of the Hungarian version of the ICECAP-A and ICECAP-O questionnaires and population normative data. Qual Life Res. 2020;29(10):2863–74.CrossRef
33.
go back to reference Flynn TN, Huynh E, Peters TJ, Al-Janabi H, Clemens S, Moody A, et al. Scoring the Icecap-a capability instrument. Estimation of a UK general population tariff. Health Econ. 2015;24(3):258–69.CrossRef Flynn TN, Huynh E, Peters TJ, Al-Janabi H, Clemens S, Moody A, et al. Scoring the Icecap-a capability instrument. Estimation of a UK general population tariff. Health Econ. 2015;24(3):258–69.CrossRef
34.
go back to reference Topp C, Østergaard S, Søndergaard S, Bech P. The WHO-5 well-being index: a systematic review of the literature. Psychother Psychosom. 2015;84:167–76.CrossRef Topp C, Østergaard S, Søndergaard S, Bech P. The WHO-5 well-being index: a systematic review of the literature. Psychother Psychosom. 2015;84:167–76.CrossRef
35.
go back to reference Prinsen CAC, Mokkink LB, Bouter LM, Alonso J, Patrick DL, de Vet HCW, et al. COSMIN guideline for systematic reviews of patient-reported outcome measures. Qual Life Res. 2018;27(5):1147–57.CrossRef Prinsen CAC, Mokkink LB, Bouter LM, Alonso J, Patrick DL, de Vet HCW, et al. COSMIN guideline for systematic reviews of patient-reported outcome measures. Qual Life Res. 2018;27(5):1147–57.CrossRef
36.
go back to reference Cohen J. Set correlation and contingency tables. Appl Psychol Meas. 1988;12(4):425–34.CrossRef Cohen J. Set correlation and contingency tables. Appl Psychol Meas. 1988;12(4):425–34.CrossRef
37.
go back to reference Bland JM, Altman DG. Statistics notes: Cronbach’s alpha. BMJ. 1997;314(7080):572.CrossRef Bland JM, Altman DG. Statistics notes: Cronbach’s alpha. BMJ. 1997;314(7080):572.CrossRef
38.
go back to reference Koo TK, Li MY. A guideline of selecting and reporting intraclass correlation coefficients for reliability research. J Chiropr Med. 2016;15(2):155–63.CrossRef Koo TK, Li MY. A guideline of selecting and reporting intraclass correlation coefficients for reliability research. J Chiropr Med. 2016;15(2):155–63.CrossRef
39.
go back to reference Devlin NJ, Shah KK. Valuing health-related quality of life: An EQ-5D-5L value set for England. 2018;27(1):7–22. Devlin NJ, Shah KK. Valuing health-related quality of life: An EQ-5D-5L value set for England. 2018;27(1):7–22.
40.
go back to reference Akkubak Y, AnaforoĞluKÜlÜnkoĞlu B. Reliability and validity of the Turkish Version of Arthritis Research UK Musculoskeletal Health Questionnaire. Arch Rheumatol. 2020;35(2):155–62.CrossRef Akkubak Y, AnaforoĞluKÜlÜnkoĞlu B. Reliability and validity of the Turkish Version of Arthritis Research UK Musculoskeletal Health Questionnaire. Arch Rheumatol. 2020;35(2):155–62.CrossRef
41.
go back to reference Burgess R, Lewis M, Hill JC. Musculoskeletal case-mix adjustment in a UK primary/community care cohort: Testing musculoskeletal models to make recommendations in this setting. Musculoskelet Sci Pract. 2021;56:102455.CrossRef Burgess R, Lewis M, Hill JC. Musculoskeletal case-mix adjustment in a UK primary/community care cohort: Testing musculoskeletal models to make recommendations in this setting. Musculoskelet Sci Pract. 2021;56:102455.CrossRef
Metadata
Title
Validation of the Musculoskeletal Health Questionnaire in a general population sample: a cross-sectional online survey in Hungary
Authors
Áron Hölgyesi
Gyula Poór
Petra Baji
Zsombor Zrubka
Miklós Farkas
Ágota Dobos
László Gulácsi
Levente Kovács
Márta Péntek
Publication date
01-12-2022
Publisher
BioMed Central
Published in
BMC Musculoskeletal Disorders / Issue 1/2022
Electronic ISSN: 1471-2474
DOI
https://doi.org/10.1186/s12891-022-05716-9

Other articles of this Issue 1/2022

BMC Musculoskeletal Disorders 1/2022 Go to the issue